EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Approach With Caution: A Pilot Randomised Controlled Trial of Approach Bias Modification for People Undergoing Residential Treatment for Methamphetamine Use Disorder

Victoria Manning iD, Danielle Whelan iD, Hugh Piercy iD, Malcolm Hopwood, Michael Maloney, Eli Kotler, Goke Okedara, Dan I Lubman, Shalini Arunogiri iD, Joshua B B Garfield iD

Drug and Alcohol Review · 2026-05 · 45 (4)

DOI: 10.1111/dar.70151 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug and Alcohol Review, online erschienen am 01.04.2026. Verfasst von Victoria Manning und 9 weiteren Autor:innen. Beteiligte Einrichtung: Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Australia. Hauptthemen laut MEDLINE: Amphetamine-Related Disorders, Cognitive Behavioral Therapy, Methamphetamine, Residential Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Centre for Clinical Research on Emerging Drugs (NCCRED).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Less than one‐quarter of people who attend residential rehabilitation for methamphetamine use disorder (MUD) remain abstinent for 1 year. Approach bias modification (ApBM), a cognitive training intervention, reduces relapse rates when delivered during residential rehabilitation for alcohol use disorder. However, there has been little research on ApBM for MUD.

Methods

Twenty‐four patients with MUD attending four residential treatment services in Melbourne were randomised, between March 2020 and August 2024, to 6 sessions of either ApBM ( n = 10) or sham‐control training ( n = 14). Safety was monitored during the intervention and acceptability was assessed at the end of training. A blinded researcher assessed methamphetamine use, craving, and dependence severity at follow‐ups 1 and 3 months after discharge from residential treatment.

Results

Three ApBM and five control participants experienced adverse psychological reactions to the training task, resulting in two ApBM and 1 control participants withdrawing. However, participants who completed training generally provided positive acceptability ratings (mean Endorsement and Discomfort Scale scores of 69.13 [SD = 10.93] in the ApBM group and 58.83 [SD = 13.41] in controls). Directions of differences in proportions reporting past‐month abstinence at 1‐month (ApBM: 5/7 [71%]; controls: 5/11 [46%]) and 3‐month follow‐ups (ApBM: 4/7 [57%]; controls: 3/9 [33%]) and continuous abstinence at 3‐month follow‐up (ApBM: 3/7 [43%]; controls: 2/11 [18%]) favoured ApBM; however, these differences did not approach significance in this very small sample. Craving and MUD severity outcomes also did not differ significantly between groups. Discussion and Conclusions Further research on ApBM's efficacy for MUD may be warranted, but safety concerns suggest caution. Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN12620000072910. Registered on 30 January 2020 (prospectively registered): https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=378804&isReview=true .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amphetamine-Related DisordersCognitive Behavioral TherapyMethamphetamineResidential TreatmentAdultFemaleHumansMaleMiddle AgedCognitive TrainingPilot Projects

Stichwörter der Autor:innen

approach bias modificationcognitive bias modificationinpatient treatmentmethamphetamineresidential rehabilitation

Substanzen

Methamphetamine

Autor:innen und Institutionen

  • Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Australia.
  • Turning Point, Eastern Health, Melbourne, Australia.
  • Department of Psychiatry, University of Melbourne, Melbourne, Australia.
  • Ramsay Clinic Albert Road, Ramsay Health, Melbourne, Australia.
  • The Melbourne Clinic, Healthscope, Melbourne, Australia.
  • Malvern Private Hospital, Melbourne, Australia.

ORCID-Profile: Victoria Manning, Danielle Whelan, Hugh Piercy, Shalini Arunogiri, Joshua B B Garfield

Förderung

  • National Centre for Clinical Research on Emerging Drugs (NCCRED)

Zitieren

APA

Manning, V., Whelan, D., Piercy, H., Hopwood, M., Maloney, M., Kotler, E., Okedara, G., Lubman, D. I., Arunogiri, S., & Garfield, J. B. B. (2026). Approach With Caution: A Pilot Randomised Controlled Trial of Approach Bias Modification for People Undergoing Residential Treatment for Methamphetamine Use Disorder. Drug and Alcohol Review, 45(4). https://doi.org/10.1111/dar.70151

Vancouver

Manning V, Whelan D, Piercy H, Hopwood M, Maloney M, Kotler E, et al. Approach With Caution: A Pilot Randomised Controlled Trial of Approach Bias Modification for People Undergoing Residential Treatment for Methamphetamine Use Disorder. Drug and Alcohol Review. 2026;45(4). doi:10.1111/dar.70151

BibTeX
@article{Manning2026,
  author = {Manning, Victoria and Whelan, Danielle and Piercy, Hugh and Hopwood, Malcolm and Maloney, Michael and Kotler, Eli and Okedara, Goke and Lubman, Dan I and Arunogiri, Shalini and Garfield, Joshua B B},
  title = {Approach With Caution: A Pilot Randomised Controlled Trial of Approach Bias Modification for People Undergoing Residential Treatment for Methamphetamine Use Disorder},
  journal = {Drug and Alcohol Review},
  year = {2026},
  volume = {45},
  number = {4},
  doi = {10.1111/dar.70151}
}
Kostenlos starten →